-+ 0.00%
-+ 0.00%
-+ 0.00%

ALVOTECH ANNOUNCES FDA ACCEPTANCE FOR REVIEW OF BIOLOGICS LICENSE APPLICATION FOR AVT80, EXPANDING PROPOSED BIOSIMILAR PROGRAM FOR ENTYVIO® TO SUBCUTANEOUS PRESENTATIONS

Reuters·08/31/2026 08:30:00

Please log in to view news